Larry Berman CFA, CMT, CTAPowershares Dynamic Pharmaceuticals PortfolioPJPSELLSep 14, 2015

US Phama that trades in US dollars. They have had a big run and more volatility could bring more downside to the high fliers within the sector.

Larry Berman CFA, CMT, CTA

Unknown

Unlock Rating

$75.49

Stock price when the opinion was issued

$114.09

As of Jun 23, 2026. Market Open.

E.T.F.'s

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

DON'T BUY

This has a fairly large contingent of big Pharma, possibly 50%. He is staying away from big Pharma simply because he thinks there are a lot of lawsuits that are going to be coming out because of the way they mispriced a number of drugs.

Most Recent Experts

Paul Harris, CFA

Harris Douglas Asset Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Jim Lebenthal

Cerity Partners

Joe Terranova

Virtus Investment Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Larry Berman CFA, CMT, CTAPowershares Dynamic Pharmaceuticals PortfolioPJPSELLSep 14, 2015

You might be interested:

Powershares Dynamic Pharmaceuticals Portfolio(PJP)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals